ADALIMUMAB LONG-TERM EFFECTIVENESS IN ADALIMUMAB-NAIVE PATIENTS WITH CROHN'S DISEASE: FINAL DATA FROM PYRAMID REGISTRY

被引：0
|
作者：
Loftus, Edward V.
D'Haens, Geert R.
Reinisch, Walter
Satsangi, Jack
Panaccione, Remo
Berg, Sofie
Alperovich, Gabriela
Bereswill, Mareike
Skup, Martha
Petersson, Joel H.
Robinson, Anne M.
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)32582-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1661
引用
收藏
页码：S743 / S743
页数：1
相关论文
共 50 条
  • [21] Long-term outcomes of adalimumab in patients with Crohn's disease: Can a doubled dose of adalimumab improve outcomes?
    Kanazawa, J.
    Yokoyama, K.
    Matsumoto, Y.
    Kawagishi, K.
    Mukae, M.
    Kubota, M.
    Kobayashi, K.
    Koizumi, W.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S367 - S368
  • [22] Long-Term Efficacy and Safety of Adalimumab in Paediatric Patients With Crohn's Disease
    Faubion, William
    Dubinsky, Marla
    Ruemmele, Frank
    Escher, Johanna
    Rosh, Joel R.
    Hyams, Jeffrey S.
    Eichner, Samantha
    Li, Yao
    Reilly, Nattanan
    Robinson, Anne M.
    Lazar, Andreas
    GASTROENTEROLOGY, 2016, 150 (04) : S775 - S775
  • [23] PYRAMID Registry: Observational Study of Adalimumab in Crohn's Disease at Year 2
    D'Haens, Geert
    Reinisch, Walter
    Satsangi, Jack
    Loftus, Edward
    Panaccione, Remo
    Tokimoto, Debbie
    McNamee, Lawrence
    Lomax, Kathleen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S431 - S431
  • [24] Long-term efficacy of adalimumab in Paediatric Crohn's disease patients naive to other anti-TNF therapies
    Martin-de-Carpi, J.
    Pociello, N.
    Varea, V.
    JOURNAL OF CROHNS & COLITIS, 2010, 4 (05): : 594 - 598
  • [25] Adalimumab and Crohn's disease; A long-term real world experience
    Iqbal, J.
    Kemp, K.
    Hodgins, J.
    Chan, L.
    Willert, R.
    Makin, A.
    Campbell, S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A88 - A88
  • [26] Long-term deep remission after adalimumab discontinuation in Crohn's disease patients
    Melotti, L.
    Rizzello, F.
    Calabrese, C.
    Dussias, N.
    Gionchetti, P.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S423 - S423
  • [27] Long-Term Durability of Response to Adalimumab Treatment in Crohn's Disease
    Chaparro, Maria
    Panes, Julian
    Garcia, V.
    Merino, Olga
    Nos, Pilar
    Domenech, Eugeni
    Penalva, Mireia
    Garcia-Planella, Esther
    Esteve, Maria
    Hinojosa, Joaquin
    Andreu, Montserrat
    Munoz, Fernando
    Gutierrez, Ana
    Mendoza, Juan L.
    Barrio, Jesus
    Barreiro, Manuel
    Vera, Isabel
    Vilar, Pere
    Cabriada, Jose Luis
    Montoro, Miguel A.
    Mante, Xavier Aldeguer
    Saro, Cristina
    Gisbert, Javier P.
    GASTROENTEROLOGY, 2010, 138 (05) : S689 - S689
  • [28] Long-Term Outcomes With Adalimumab Therapy in Pediatric Crohn Disease: Associations With Adalimumab Exposure
    Rinawi, Firas
    Popalis, Cynthia
    Tersigni, Claudia
    Frost, Karen
    Muise, Aleixo
    Church, Peter C.
    Walters, Thomas D.
    Ricciuto, Amanda
    Griffiths, Anne M.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2022, 74 (03): : 389 - 395
  • [29] Adalimumab trough serum levels and anti-adalimumab antibodies in the long-term clinical outcome of patients with Crohn's disease
    Bodini, Giorgia
    Giannini, Edoardo G.
    Savarino, Vincenzo
    Del Nero, Lorenzo
    Pellegatta, Gaia
    De Maria, Costanza
    Baldissarro, Isabella
    Savarino, Edoardo
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (09) : 1081 - 1086
  • [30] PYRAMID Registry: Observational study of adalimumab in Crohn's disease at year 2.
    D'Haens, G.
    Reinisch, W.
    Satsangi, J.
    Loftus, E., Jr.
    Panaccione, R.
    Tokimoto, D.
    McNamee, L.
    Lomax, K.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 : S44 - S45
12345